tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MorphoSys narrows FY23 Monjuvi U.S. net product sales to $85M-$95M

Prior guidance was $80M-$95M. Lowers gross margin for Monjuvi U.S. net product sales to about 75% from 75%-80%.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on MOR:

Disclaimer & DisclosureReport an Issue

1